Paratek Pharmaceuticals Inc expected to post a loss of 41  cents a share - Earnings Preview

Paratek Pharmaceuticals

18/02/2022 21:02

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports  results on
February 22 (estimated). 
    * The Boston Massachusetts-based  company is expected to
report  a
120.6% increase in revenue to $35.343 million from $16.02
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Paratek
Pharmaceuticals
Inc is for a loss of 41 cents per share. For the same quarter
last year, the company reported a loss of 60 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $21​, about 82.2% above​ its last closing
price of $3.73. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.44       -0.45      -0.37     Beat    17.8
 Jun. 30 2021  0.35        0.32       0.20      Missed  -36.5
 Mar. 31 2021  -0.40       -0.38      -0.39     Missed  -2.1​
 Dec. 31 2020  -0.12       -0.04      -0.60     Missed  -1,233
                                                        .3
 ​​Sep.        -0.61       -0.61      -0.46     Beat    24.6
 30 2020                                                
 Jun. 30 2020  -0.23       -0.06      -0.53     Missed  -748​
 Mar. 31 2020  -0.88       -0.80      -0.66     Beat    17.8
 Dec. 31 2019  -0.75       -0.81      -0.81     Met     -0.2
 This summary was machine generated February 18 at 21:02 GMT. 
All figures in US dollars  unless otherwise stated